UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549
	SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 6)*

(Name of Issuer)

 

(Title of Class of Securities)

 

(CUSIP Number)

 

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

---

 

 

2

---

This statement constitutes Amendment No. 6 to the statement on Schedule 13D as previously filed (the “Original Schedule 13D”) by the Enron Disputed Claims Reserve on April 5, 2006, as amended by Amendment No. 1 filed on May 3, 2006, and as further amended by Amendment No. 2 filed on June 2, 2006, Amendment No. 3 filed on October 3, 2006, Amendment No. 4 filed on February 1, 2007, and Amendment No. 5 filed on April 2, 2007.  Unless specifically defined herein, capitalized terms shall have the same meaning as set forth in the Original Schedule 13D. 

 

Item 5.

Interest in Securities of the Issuer

Sub-items (a) and (b) of Item 5 are amended and restated in their entirety as follows: (a) and (b)  For the purpose of Rule 13d-3 promulgated under the Exchange Act, the Reporting Person owns no shares of Common Stock and does not have voting or dispositive power with respect to any shares of Common Stock. Sub-item (c) of Item 5 is hereby amended to add the following information: On June 1, 2007, 324,293 shares of Common Stock were distributed from the DCR to holders of allowed claims pursuant to the Plan.  In addition, on June 18, 2007, the remaining 23,658,106 shares of Common Stock owned by the DCR were offered and sold to the public, through an underwritten public offering, at a price of $26.00 per share.  Sub-item (e) of Item 5 is hereby amended and restated in its entirety as follows: (e)  On June 18, 2007, the DCR ceased to be the beneficial owner of more than five percent of the outstanding shares of Common Stock.

 

3

---

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: June 20, 2007

		Enron Disputed Claims Reserve
		By: BDHLR, LLC, as Disbursing Agent
		/s/ John J. Ray, III
		John J. Ray, III, President

 

4